NIBIB Trailblazer R21
Funds exploratory biomedical engineering research led by emerging investigators through United States health innovation support.
⚠This may reflect a past cycle — verify the current call on the funder's site.
The NIBIB Trailblazer Award (PA-25-169, R21 Clinical Trial Not Allowed) is a dedicated funding mechanism from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) that supports New Investigators and Early Stage Investigators pursuing high-risk, high-reward research at the interface of life sciences, engineering, and physical sciences. NIBIB's mission — to transform understanding…
Research at the interface of life sciences with engineering and physical sciences; exploratory, developmental, proof-of-concept, or high-risk/high-impact projects. Minimal or no preliminary data expected.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline